Search

Your search keyword '"Cunningham, Douglas"' showing total 252 results

Search Constraints

Start Over You searched for: Author "Cunningham, Douglas" Remove constraint Author: "Cunningham, Douglas"
252 results on '"Cunningham, Douglas"'

Search Results

1. Shuffle Vision Transformer: Lightweight, Fast and Efficient Recognition of Driver Facial Expression

2. Perception of Line Attributes for Visualization

3. Perceptually Uniform Construction of Illustrative Textures

5. Log-centric airbase-opening strategies in Korea

7. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

10. A Specialized Pipeline for Efficient and Reliable 3D Semantic Model Reconstruction of Buildings from Indoor Point Clouds.

11. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

12. 3D reconstruction of partial foot scans using different state of the art neural network approaches.

13. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

15. 1567. Perspectives of People with HIV (PWH) 6 Months Following a Switch to Cabotegravir and Rilpivirine Long-acting (CAB+RPV LA) in an Observational Real-world US Study (BEYOND)

16. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

17. The Face Speaks: Contextual and Temporal Sensitivity to Backchannel Responses

22. Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

23. Perceptually Uniform Construction of Illustrative Textures

24. Perception of Line Attributes for Visualization

27. The Perceptual Influence of Spatiotemporal Noise on the Reconstruction of Shape from Dynamic Occlusion

29. Perceptual Evaluation of Common Line Variables for Displaying Uncertainty on Molecular Surfaces

33. Explosive structure: fragmenting the new modernist war narrative in The Hurt Locker

34. Context Aware Exemplar-based Image Inpainting using Irregular Patches

42. Enlighten Me

47. Correction to Method of Establishing the Absolute Radiometric Accuracy of Remote Sensing Systems While On-orbit Using Characterized Stellar Sources

50. Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

Catalog

Books, media, physical & digital resources